POLR2M encodes Gdown1, a stably associated subunit of RNA polymerase II (Pol II) that regulates transcription through multiple mechanisms 1. Structurally, Gdown1 binds to the Rpb5 shelf-Rpb1 jaw region of Pol II and sterically blocks TFIIF binding, thereby inhibiting transcription initiation at promoters 2. This repressive function is relieved by the Mediator coactivator complex, restoring Pol II-dependent transcription 1. Gdown1 also stabilizes promoter-proximally paused polymerases while maintaining their responsiveness to P-TEFb-mediated release into productive elongation 1. Interestingly, Gdown1 is predominantly cytoplasmic during interphase and accumulates in the nucleus during mitosis, where it functions to suppress mitotic transcription and maintain genome integrity 3. In disease contexts, POLR2M participates in oncogenic mechanisms: genome-wide CRISPR screens identified POLR2M as a critical regulator of MIR139 silencing downstream of the MLL-AF9 fusion protein and PRC2 in acute myeloid leukemia 4. Additionally, POLR2M is part of the GRINL1A complex transcription unit on chromosome 15; homozygous GCOM1 variants in this unit cause fully penetrant recessive dilated cardiomyopathy 5. These findings establish POLR2M as a multifunctional regulator of Pol II activity with roles in transcriptional control, cell cycle regulation, and disease pathogenesis.